Angélique Robin

920 total citations
10 papers, 198 citations indexed

About

Angélique Robin is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angélique Robin has authored 10 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angélique Robin's work include DNA Repair Mechanisms (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and PARP inhibition in cancer therapy (2 papers). Angélique Robin is often cited by papers focused on DNA Repair Mechanisms (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and PARP inhibition in cancer therapy (2 papers). Angélique Robin collaborates with scholars based in France, United States and Malaysia. Angélique Robin's co-authors include Jean‐Charles Soria, Ken A. Olaussen, Julien Adam, Émilie Louvet, Aïcha Goubar, Stéphane Temam, Tony Sourisseau, Laura Faivre, Luc Friboulet and Caroline Even and has published in prestigious journals such as Annals of Oncology, Cell Cycle and BMC Cancer.

In The Last Decade

Angélique Robin

10 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angélique Robin France	7	139	85	40	37	36	10	198
Yuanhao Liu China	8	52 0.4×	79 0.9×	52 1.3×	43 1.2×	22 0.6×	20	186
Daiyuan Ma China	10	139 1.0×	77 0.9×	55 1.4×	110 3.0×	65 1.8×	40	274
Giulia Querzoli Italy	6	121 0.9×	82 1.0×	90 2.3×	40 1.1×	24 0.7×	22	229
Miao Huang China	9	184 1.3×	61 0.7×	44 1.1×	159 4.3×	50 1.4×	17	298
Phuong Vu Norway	7	139 1.0×	107 1.3×	106 2.6×	64 1.7×	10 0.3×	12	258
Omar Saavedra Spain	9	66 0.5×	86 1.0×	14 0.3×	16 0.4×	36 1.0×	22	167
Puchun Er China	8	68 0.5×	96 1.1×	51 1.3×	55 1.5×	24 0.7×	15	193
Takuma Onoe Japan	8	141 1.0×	59 0.7×	23 0.6×	83 2.2×	22 0.6×	19	236
María José Paúles Spain	6	134 1.0×	53 0.6×	39 1.0×	34 0.9×	29 0.8×	14	198
Emilie Sohier France	5	54 0.4×	48 0.6×	30 0.8×	16 0.4×	18 0.5×	7	128

Countries citing papers authored by Angélique Robin

Since Specialization

Citations

This map shows the geographic impact of Angélique Robin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angélique Robin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angélique Robin more than expected).

Fields of papers citing papers by Angélique Robin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angélique Robin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angélique Robin. The network helps show where Angélique Robin may publish in the future.

Co-authorship network of co-authors of Angélique Robin

This figure shows the co-authorship network connecting the top 25 collaborators of Angélique Robin. A scholar is included among the top collaborators of Angélique Robin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angélique Robin. Angélique Robin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Adam, Julien, Émilie Louvet, Tony Sourisseau, et al.. (2018). TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma. ESMO Open. 3(1). e000257–e000257. 69 indexed citations

2.

Kuo, Mei-Shiue, Julien Adam, Nicolas Dorvault, et al.. (2018). A novel antibody-based approach to detect the functional ERCC1-202 isoform. DNA repair. 64. 34–44. 6 indexed citations

3.

Rouanne, Mathieu, Julien Adam, Aïcha Goubar, et al.. (2016). Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer. BMC Cancer. 16(1). 483–483. 32 indexed citations

4.

Adam, Julien, Tony Sourisseau, Ken A. Olaussen, et al.. (2016). MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer. Cancer Biomarkers. 17(3). 323–333. 4 indexed citations

5.

Michels, Judith, Julien Adam, Aïcha Goubar, et al.. (2015). Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer. Annals of Oncology. 26(12). 2470–2477. 19 indexed citations

6.

Vanhecke, Elsa, Alexander Valent, Ximing Tang, et al.. (2013). 19q13-ERCC1 Gene Copy Number Increase in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 14(5). 549–557. 8 indexed citations

7.

Olaussen, Ken A., Julien Adam, Elsa Vanhecke, et al.. (2013). PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outs. Lung Cancer. 80(2). 216–222. 39 indexed citations

8.

Galluzzi, Lorenzo, Aïcha Goubar, Ken A. Olaussen, et al.. (2013). Prognostic value of LIPC in non-small cell lung carcinoma. Cell Cycle. 12(4). 647–654. 16 indexed citations

9.

Robin, Angélique, Machelle Wilson, & Andrew Evans. (2006). Over-diagnosis and breast cancer screening. European Journal of Cancer Supplements. 4(2). 6–9. 3 indexed citations

10.

Robin, Angélique, et al.. (2006). European Group for Breast Cancer Screening: Breast Cancer Screening in Europe — current status. European Journal of Cancer Supplements. 4(2). 4–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact